Dr. Giles is an experienced pharmaceutical executive with over 20+ years of drug development experienced, as global strategy director of asthma at GSK, global director pharmacology at Glaxo Welcome and VP, Drug Development, Encysive Pharmaceuticals. PhD Pharmacology, University of London

Dr. Farmer has substantial industry experience directing CMC activities and overseeing GMP manufacture of pharmaceuticals.Dr. Farmer was previously Director of Analytical Services at Encysive, where she led the teams responsible for analytical and bioanalytical chemistry from drug discovery through to the market. Ph.D. in Biochemistry from the UT-Health Science Center in Houston and a B.S. in Chemistry from the University of Tulsa.

Ms. Motter has 25+ years of experience in both public and privately held companies. She earned her MBA from the UCLA Anderson School of Management and worked as an Auditor with KPMG prior to entering the private sector working in life sciences. Ms. Motter has been involved with companies in all stages of development. She has been the CFO for many life science companies including: LifeCell, Repros, Chrysalis, Aronex, and RGene.

Danguole Altman is an experienced health care CEO. Ex-CEO FemPartners, a successful women's health care services company she founded and raised $15M+ to capitalize. Ex- McKinsey consultant, HCA. AB Economics Harvard, MBA Yale